DAPAGLIFLOZIN for Diabetes mellitus: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 3,347 adverse event reports in the FDA FAERS database where DAPAGLIFLOZIN was used for Diabetes mellitus.
Most Reported Side Effects for DAPAGLIFLOZIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 2,775 | 13.0% | 2,774 | 52 |
| Diabetic ketoacidosis | 1,773 | 8.3% | 61 | 1,154 |
| Acute kidney injury | 982 | 4.6% | 67 | 768 |
| Off label use | 891 | 4.2% | 28 | 310 |
| Nausea | 884 | 4.1% | 20 | 363 |
| Dehydration | 860 | 4.0% | 67 | 451 |
| Vomiting | 838 | 3.9% | 27 | 419 |
| Dizziness | 817 | 3.8% | 30 | 293 |
| Ketoacidosis | 803 | 3.8% | 30 | 471 |
| Fatigue | 785 | 3.7% | 8 | 227 |
| Diarrhoea | 769 | 3.6% | 32 | 317 |
| Dyspnoea | 760 | 3.6% | 21 | 328 |
| Malaise | 737 | 3.5% | 30 | 308 |
| Weight decreased | 727 | 3.4% | 23 | 231 |
| Blood glucose increased | 699 | 3.3% | 12 | 247 |
Other Indications for DAPAGLIFLOZIN
Type 2 diabetes mellitus (5,444)
Product used for unknown indication (1,534)
Cardiac failure (1,332)
Chronic kidney disease (585)
Ill-defined disorder (556)
Cardiac failure chronic (498)
Type 1 diabetes mellitus (308)
Blood glucose increased (145)
Blood glucose abnormal (127)
Blood glucose decreased (72)
Other Drugs Used for Diabetes mellitus
ROSIGLITAZONE (45,088)
INSULIN GLARGINE (19,253)
METFORMIN (17,371)
INSULIN LISPRO (16,084)
DULAGLUTIDE (7,557)
INSULIN HUMAN (6,813)
TIRZEPATIDE (5,209)
SITAGLIPTIN (4,792)
METFORMIN\ROSIGLITAZONE (4,438)
EMPAGLIFLOZIN (4,267)